Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Evaluation of Patients Who Have Not Had Success With Zidovudine

ClinicalTrials.gov ID: NCT00001025

Public ClinicalTrials.gov record NCT00001025. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 5, 2026, 10:13 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Study to Evaluate the Short-Term Clinical and Virologic Significance of Zidovudine Resistance

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To determine the relationship of viral susceptibility to zidovudine (AZT) and baseline viral load (as determined by plasma viremia and quantitative endpoint dilution). To determine the relationship between viral load and susceptibility during different antiretroviral therapy strategies. To correlate measures of viral load and short term clinical and laboratory markers (such as weight, CD4 count, p24 antigenemia, and beta2 microglobulin) on the different therapy arms. High-grade resistance to AZT has been detected in HIV isolates from approximately 25 percent of individuals with AIDS who received AZT for at least 1 year. To elucidate the clinical significance of in vitro AZT resistance, it is necessary to distinguish between clinical failure caused by AZT resistance and clinical decompensation caused by other factors.

Study identification

NCT ID
NCT00001025
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
120 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Apr 30, 1995
Last update posted
Oct 31, 2021

Ends 1995

United States locations

U.S. sites
18
U.S. states
9
U.S. cities
14
Facility City State ZIP Site status
Univ of Alabama at Birmingham Birmingham Alabama 35294
San Francisco Gen Hosp San Francisco California 941102859
Santa Clara Valley Med Ctr / AIDS Community Rsch Consortium San Jose California 951282699
San Mateo AIDS Program / Stanford Univ Stanford California 943055107
Kaiser Permanente Franklin Med Ctr Denver Colorado 80262
Univ of Colorado Health Sciences Ctr Denver Colorado 80262
Children's Mem Hosp Family Cln / Northwestern Univ Med Schl Chicago Illinois 60611
Northwestern Univ Med School Chicago Illinois 60611
Cook County Hosp Chicago Illinois 60612
Rush Presbyterian - Saint Luke's Med Ctr Chicago Illinois 60612
Baystate Med Ctr of Springfield Springfield Massachusetts 01199
Univ of Minnesota Minneapolis Minnesota 55455
Univ of Nebraska Med Ctr Omaha Nebraska 681985130
SUNY / Health Sciences Ctr at Brooklyn Brooklyn New York 112032098
SUNY / Erie County Med Ctr at Buffalo Buffalo New York 14215
Univ of Rochester Medical Center Rochester New York 14642
SUNY / State Univ of New York Syracuse New York 13210
Univ of Washington Seattle Washington 981224304

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00001025, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 31, 2021 · Synced Sep 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00001025 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →